Endpoint definition
↥| Name | CD2_INSITU_BREAST_LOBULAR |
|---|---|
| Long name | Carcinoma in situ of breast, lobular |
| Sex specific endpoint | 2 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Carcinoma in situ lobulare mammae |
Carcinoma in situ of breast, lobular
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 74 | 74 | - |
| Unadjusted prevalence (%) | 0.03 | 0.06 | - |
| Mean age at first event (years) | 57.96 | 57.96 | - |
| Case fatality at 5-years (%) | 1.35 | 1.35 | - |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | - |
| Recurrence at 6 months (%) | 13.33 | 13.51 | - |
Survival analyses between endpoints
↥Plot
before Carcinoma in situ of breast, lobular
after Carcinoma in situ of breast, lobular
Loading survival analyses plot…
Table
Loading survival analyses table…